Logo

multiplex diagnostics

Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
Premium

The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.

Becton Dickinson Gets CE-IVD Mark for BD Max Combined COVID, Flu, RSV Panel

The firm also plans to submit the assay to the US Food and Drug Administration for Emergency Use Authorization in the coming weeks.

Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19

Results are generated in a single workflow from a patient sample, which enables rapid detection for the differential diagnosis of a single pathogen.

Seegene Maps US Diagnostics Expansion With New Hires and Chemistry, Bio-Rad Collaboration
Premium

The firm expects to establish a US-based development and manufacturing footprint for its multiplex PCR assay kits.

Anavasi Diagnostics Poised to Debut Rapid POC MDx System, COVID-19 Test
Premium

The firm submitted a low-cost RT-LAMP device and COVID test to the FDA for Emergency Use Authorization this week.

May 26, 2021

Torus Biosystems Completes $25M Series A Financing Round

May 5, 2021

US Department of Defense Awards $178.5M Contract to Hologic for SARS-CoV-2 Assays, Multiplex Tests

Jan 15, 2021

Mammoth Biosciences Taking Lead Role in DARPA-Funded Development of Pathogen Detection Tech
Premium

Jan 14, 2021

DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech

Oct 28, 2020

GenMark Q3 Revenues More Than Double on Respiratory Panel Sales

Oct 15, 2020

Scanogen Developing Direct-From-Blood Infection Test That Could Provide Results in 90 Minutes
Premium

Oct 6, 2020

Startup Coral Genomics Wins $2M SBIR Grant From NIH

Oct 2, 2020

UK Team Enhances Real-Time PCR Multiplexing Using Data Analytics
Premium

Sep 24, 2020

BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

Sep 14, 2020

GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu

Jul 17, 2020

Cepheid Debuts 10-Color Molecular Detection Technology With New Tuberculosis Test
Premium

Feb 11, 2020

Verigene II, New Assay Launches Anticipated to Revivify Luminex Revenues in 2020
Premium

Jan 30, 2020

Atila Biosystems High-Throughput Isothermal HPV Test Validated in Study
Premium

Jan 15, 2020

JP Morgan Healthcare Day 2: 10x Genomics, GenapSys, Caris, Adaptive Bio, Danaher, Agilent, Luminex

Dec 18, 2019

Rapid Diagnostics Resurrects Multiplex MiniLab Platform, Targets TB POC Test
Premium

Dec 17, 2019

ChromaCode Raises $28M in Series C Financing

Sep 12, 2019

Applied BioCode Submits Respiratory Pathogen Panel to FDA

Aug 27, 2019

After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance
Premium

Aug 5, 2019

GenMark Diagnostics Reports 23 Percent Revenue Increase in Q2

May 8, 2019

Despite Q1 Challenges, Luminex Targeting Long-Term Growth From Pipeline Products
Premium

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.